Leptomeningeal enhancement under different MS immunotherapies: A monocentric retrospective cohort study of 214 patients.

Christoph Friedli Franca WagnerHammer Helly NoemiKamber NicoleWiest RolandLara DiemChan AndrewSalmen AnkeHoepner Robert

Published in: Multiple sclerosis (Houndmills, Basingstoke, England) (2022)

We observed LME resolution under treatment with anti-CD20 therapies. As LME might play an important role in cerebral gray matter pathology in MS, further investigations including extensions to higher field strengths, correlation with clinical phenotypes, and comparison with other immunotherapies are needed.

Keyphrases

mass spectrometry
multiple sclerosis
ms ms
subarachnoid hemorrhage
cross sectional
small cell lung cancer
single molecule
cerebrospinal fluid
replacement therapy
brain metastases
clinical evaluation